Phase II trial of combined irinotecan and oxaliplatin given...

Phase II trial of combined irinotecan and oxaliplatin given every 3 weeks to patients with metastatic colorectal cancer

Paulo M. Hoff, Robert A. Wolff, Henry Xiong, Dennie Jones, Edward Lin, Cathy Eng, Ankhi Dutta, Karla R. Bogaard, James L. Abbruzzese
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
106
Year:
2006
Language:
english
Pages:
6
DOI:
10.1002/cncr.21874
File:
PDF, 92 KB
english, 2006
Conversion to is in progress
Conversion to is failed